Clinical Trials on VTE (Venous Thromboembolism) in United Kingdom

Total 1689 results

Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Risk Factors for Venous Thromboembolism in the Community

Cardiovascular Diseases | Thromboembolism

United States
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
Sanofi

Completed

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery (SAVE-HIP1)

Venous Thromboembolism

United States, Canada, Poland, Romania, Russian Federation, Ukraine, Germany, Italy, Spain, Sweden, Turkey, Estonia, India, Philippines, Czech Republic, Mexico, Argentina, Denmark, Finland, Norway, Colombia, Peru, Slovakia, Australia, C... and more
Brigham and Women's Hospital
Sanofi

Completed

Epidemiology of Venous Thromboembolism

Cancer | Deep Vein Thrombosis | Venous Thromboembolism | COPD | Pulmonary Embolism

United States
Montefiore Medical Center
The Plastic Surgery Foundation

Completed

Use of Tranexamic Acid in Reduction Mammoplasty (TREX-ARM)

Venous Thromboembolism | Hematoma Postoperative

United States
University of Utah

Completed

Evaluation of Anti-Xa Levels in Surgery Patients Receiving Weight-based Heparin

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Washington University School of Medicine
Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI) and other collaborators

Completed

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis (ATTRACT)

Venous Thrombosis | Deep Vein Thrombosis | Postphlebitic Syndrome | Venous Thromboembolism | Post Thrombotic Syndrome

United States
Denver Health and Hospital Authority

Terminated

STAT-STatin and Aspirin in Trauma (STAT)

Wounds and Injuries | Venous Thromboembolism

United States
DSM Nutritional Products, Inc.

Completed

Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device

Thromboembolic Events

Germany, United States, Switzerland
University Medical Center Groningen

Terminated

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism (Longheva)

Neoplasms | Venous Thromboembolism

Netherlands, United States, Canada, Italy, Germany
Scripps Health
Medical University of South Carolina; Johns Hopkins University; Massachusetts... and other collaborators

Withdrawn

Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients (CLOTT)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United States
University of Texas Southwestern Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Thrombosis Outcomes in Pediatric Venous Thromboembolism (TOP)

Venous Thromboembolism

United States
VA Office of Research and Development

Completed

Improving Anticoagulation Control in VISN 1

Atrial Fibrillation | Venous Thromboembolism | Anticoagulants

United States
Bayer
Janssen Scientific Affairs, LLC

Completed

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) (EinsteinChoice)

Thrombosis | Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Pulmonary Embolism

Belgium, France, China, Switzerland, New Zealand, South Africa, Hungary, United States, Canada, Australia, Netherlands, Spain, Russian Federation, Austria, Mexico, Taiwan, Brazil, Czechia, Denmark, Germany, Israel, Italy, Korea, Republic... and more
Bayer

Completed

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. (RECORD 4)

Venous Thromboembolism

Poland, United States, India, Denmark, Canada, Sweden, Bulgaria, Israel, Lithuania, Norway, Pakistan, Mexico, Sri Lanka
BiO2 Medical

Terminated

Angel® Catheter Early Feasibility Clinical Study

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Indiana University

Completed

RAMBLE - Rivaroxaban vs. Apixaban for Heavy Menstrual Bleeding ((RAMBLE))

Venous Thromboembolism | Menstruation

United States
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients (MAGELLAN)

Venous Thromboembolism

Belgium, France, Norway, Spain, China, Taiwan, United States, Switzerland, Colombia, Canada, Estonia, New Zealand, Finland, Italy, Portugal, Japan, Singapore, Germany, Greece, Australia, Sweden, Austria, Chile, Slovakia, United Kingdom, M... and more
Brigham and Women's Hospital

Active, not recruiting

Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism (HI-PRO)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Brigham and Women's Hospital
Sanofi

Completed

Discharge ALERT: Quality Improvement Initiative (Discharge)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Prevention | Prophylaxis

United States
University of Colorado, Denver
Bayer

Recruiting

Treatment of Exercise-Induced Pulmonary Vascular Dysfunction in Symptomatic Patients After Pulmonary Thromboendarterectomy

Chronic Thromboembolic Disease (CTED) | Exercise Intolerance Post PEA Surgery

United States
McMaster University
Canadian Institutes of Health Research (CIHR); Australian and New Zealand Intensive... and other collaborators

Completed

PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)

Critical Illness | Deep Venous Thrombosis

United States, Australia, Canada, Saudi Arabia, Brazil, United Kingdom
Thomas Guerrero

Completed

Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events

Pulmonary Embolism | Pulmonary Thromboembolisms

United States
University of Utah

Completed

Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United States
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
Johns Hopkins University

Terminated

PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER)

Prostate Cancer | Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis | Lymphocele After Surgical Procedure

United States
University of Rochester
National Heart, Lung, and Blood Institute (NHLBI); Eisai Inc.

Terminated

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients (PHACS)

Venous Thromboembolism | Pulmonary Embolism

United States, Canada
Brigham and Women's Hospital

Completed

Prediction of the COBRRA VTE Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism | Pulmonary Embolism | DVT

United States
Bayer
Janssen Research & Development, LLC

Completed

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy (XALIA LEA)

Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

Turkey, Russian Federation, Korea, Republic of, Mexico, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Egypt, Kazakhstan, Algeria, Lebanon, Saudi Arabia, Ukraine, Jordan, Kenya, Kuwait, Morocco, Qatar, United Arab Emirates
Boehringer Ingelheim

Completed

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Venous Thromboembolism

United States, Korea, Republic of, Lebanon, Czechia, Saudi Arabia, Bulgaria, Serbia, Thailand, Greece, Malaysia, Vietnam, Belgium, Canada, United Kingdom, Turkey, Germany, Italy, Hungary, Latvia, Portugal, Russian Federation, Neth... and more
University of Utah
Stanford University

Completed

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus | Reconstructive Surgery

United States
University of Massachusetts, Worcester
Agency for Healthcare Research and Quality (AHRQ)

Completed

LEAVE Safe With DOACs

Cardiovascular Diseases | Stroke | Atrial Fibrillation | Bleeding | Venous Thromboembolism

United States
University of Utah
University of Michigan; Brigham and Women's Hospital; Kaiser Foundation Research... and other collaborators

Recruiting

Warfarin Patient Self-management Implementation in the US Healthcare System

Atrial Fibrillation | Heart Valve Diseases | Venous Thromboembolism

United States
Boehringer Ingelheim

Completed

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE (RE-SONATE)

Venous Thromboembolism

United States, Australia, Austria, Belgium, Canada, Czech Republic, Estonia, Germany, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Russian Federation, Singapore, South Africa, Sweden, Switzer... and more
Cook Group Incorporated

Completed

Study of IVC Filter Retrieval With the Günther Tulip Vena Cava Filter

Venous Thromboembolism | Pulmonary Embolism

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Atrial Fibrillation | Arterial Thromboembolic Events

United States
BiO2 Medical
Novella Clinical; CardioMed Device Consultants, LLC; Intrinsic Imaging, LLC

Completed

The Angel® Catheter Pivotal Clinical Trial

Trauma | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Bayer

Completed

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Atrial Fibrillation | Prevention of Thromboembolic Events

United States
Sanofi

Completed

Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery (SAVE-HIP3)

Venous Thromboembolism

United States, Canada, Russian Federation, Ukraine, Turkey, India, Mexico, Egypt, Lithuania, Colombia, Peru, Korea, Republic of, Chile, Belarus, China, South Africa
Momentum Data
Pfizer

Completed

The Incidence of Venous Thromboembolism in Atopic Dermatitis

Allergic Rhinitis | Deep Vein Thrombosis | Venous Thromboembolism | Atopic Dermatitis | Pulmonary Embolism | Food Allergy | Allergy to House Dust Mite | Allergy to Animal Dander | Cows Milk Allergy

United Kingdom
Boehringer Ingelheim

Completed

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Venous Thromboembolism | Secondary Prevention

United States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
GlaxoSmithKline

Completed

Odiparcil For The Prevention Of Venous Thromboembolism

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Fibrillation, Atrial

United States, Israel, Australia, South Africa, Brazil, Canada, Poland, United Kingdom, Ukraine, Lithuania, Russian Federation, India, Latvia
Imperial College London

Completed

Venous Insufficiency and Neuromuscular Stimulation (VeINS)

Venous Insufficiency | Chronic Venous Disease | Deep Venous Obstruction

United Kingdom
Imperial College London

Terminated

Venous Occlusion and Limb Swelling

Venous Occlusion

United Kingdom
McMaster University

Completed

Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection

Esophageal Cancer | Venous Thromboembolism | Thoracic Surgery

United States, Canada, China
Argon Medical Devices
NAMSA

Not yet recruiting

CLEANer Aspiration for Pulmonary Embolism (CLEAN-PE)

Cardiovascular Diseases | Venous Thromboembolism | Pulmonary Embolism | Acute Pulmonary Embolism

United States
University of Maryland, Baltimore

Completed

A Different Approach to Preventing Thrombosis (ADAPT)

Venous Thromboembolism | Pulmonary Embolism

United States
University of California, San Francisco

Recruiting

Chronic Thromboembolic Disease Registry

Chronic Thromboembolic Pulmonary Hypertension | Chronic Thromboembolic Disease

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery (TEXT-TKR)

VTE Prophylaxis With Anticoagulation After Total Knee Replacement Surgery

Belgium, Italy, Malaysia, Latvia, Spain, Turkey, Bulgaria, United States, Lithuania, Russian Federation, Ukraine, Japan, Argentina, Brazil, Canada, Poland
Daiichi Sankyo, Inc.

Completed

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Venous Thrombosis | Thromboembolism | Venous Thromboembolism | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE)

France, United States, Japan, Denmark, Italy, Russian Federation, Czechia, Germany, India, Israel, Philippines, Taiwan, Ukraine, Australia, Austria, China, Argentina, Belarus, Belgium, Brazil, Canada, Chile, Estonia, Hungary, Korea, Republic... and more

Clinical Trials on VTE (Venous Thromboembolism) in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations